Cargando…

Breast tissue, oral and urinary microbiomes in breast cancer

It has long been proposed that the gut microbiome contributes to breast carcinogenesis by modifying systemic estrogen levels. This is often cited as a possible mechanism linking breast cancer and high-fat, low-fiber diets as well as antibiotic exposure, associations previously identified in populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hannah, Altemus, Jessica, Niazi, Farshad, Green, Holly, Calhoun, Benjamin C., Sturgis, Charles, Grobmyer, Stephen R., Eng, Charis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675698/
https://www.ncbi.nlm.nih.gov/pubmed/29152146
http://dx.doi.org/10.18632/oncotarget.21490
_version_ 1783276959079333888
author Wang, Hannah
Altemus, Jessica
Niazi, Farshad
Green, Holly
Calhoun, Benjamin C.
Sturgis, Charles
Grobmyer, Stephen R.
Eng, Charis
author_facet Wang, Hannah
Altemus, Jessica
Niazi, Farshad
Green, Holly
Calhoun, Benjamin C.
Sturgis, Charles
Grobmyer, Stephen R.
Eng, Charis
author_sort Wang, Hannah
collection PubMed
description It has long been proposed that the gut microbiome contributes to breast carcinogenesis by modifying systemic estrogen levels. This is often cited as a possible mechanism linking breast cancer and high-fat, low-fiber diets as well as antibiotic exposure, associations previously identified in population-based studies. More recently, a distinct microbiome has been identified within breast milk and tissue, but few studies have characterized differences in the breast tissue microbiota of patients with and without cancer, and none have investigated distant body-site microbiomes outside of the gut. We hypothesize that cancerous breast tissue is associated with a microbiomic profile distinct from that of benign breast tissue, and that microbiomes of more distant sites, the oral cavity and urinary tract, will reflect dysbiosis as well. Fifty-seven women with invasive breast cancer undergoing mastectomy and 21 healthy women undergoing cosmetic breast surgery were enrolled. The bacterial 16S rRNA gene was amplified from urine, oral rinse and surgically collected breast tissue, sequenced, and processed through a QIIME-based bioinformatics pipeline. Cancer patient breast tissue microbiomes clustered significantly differently from non-cancer patients (p=0.03), largely driven by decreased relative abundance of Methylobacterium in cancer patients (median 0.10 vs. 0.24, p=0.03). There were no significant differences in oral rinse samples. Differences in urinary microbiomes were largely explained by menopausal status, with peri/postmenopausal women showing decreased levels of Lactobacillus. Independent of menopausal status, however, cancer patients had increased levels of gram-positive organisms including Corynebacterium (p<0.01), Staphylococcus (p=0.02), Actinomyces (p<0.01), and Propionibacteriaceae (p<0.01). Our observations suggest that the local breast microbiota differ in patients with and without breast cancer. Cancer patient urinary microbiomes were characterized by increased levels of gram-positive organisms in this study, but need to be further studied in larger cohorts.
format Online
Article
Text
id pubmed-5675698
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56756982017-11-18 Breast tissue, oral and urinary microbiomes in breast cancer Wang, Hannah Altemus, Jessica Niazi, Farshad Green, Holly Calhoun, Benjamin C. Sturgis, Charles Grobmyer, Stephen R. Eng, Charis Oncotarget Research Paper It has long been proposed that the gut microbiome contributes to breast carcinogenesis by modifying systemic estrogen levels. This is often cited as a possible mechanism linking breast cancer and high-fat, low-fiber diets as well as antibiotic exposure, associations previously identified in population-based studies. More recently, a distinct microbiome has been identified within breast milk and tissue, but few studies have characterized differences in the breast tissue microbiota of patients with and without cancer, and none have investigated distant body-site microbiomes outside of the gut. We hypothesize that cancerous breast tissue is associated with a microbiomic profile distinct from that of benign breast tissue, and that microbiomes of more distant sites, the oral cavity and urinary tract, will reflect dysbiosis as well. Fifty-seven women with invasive breast cancer undergoing mastectomy and 21 healthy women undergoing cosmetic breast surgery were enrolled. The bacterial 16S rRNA gene was amplified from urine, oral rinse and surgically collected breast tissue, sequenced, and processed through a QIIME-based bioinformatics pipeline. Cancer patient breast tissue microbiomes clustered significantly differently from non-cancer patients (p=0.03), largely driven by decreased relative abundance of Methylobacterium in cancer patients (median 0.10 vs. 0.24, p=0.03). There were no significant differences in oral rinse samples. Differences in urinary microbiomes were largely explained by menopausal status, with peri/postmenopausal women showing decreased levels of Lactobacillus. Independent of menopausal status, however, cancer patients had increased levels of gram-positive organisms including Corynebacterium (p<0.01), Staphylococcus (p=0.02), Actinomyces (p<0.01), and Propionibacteriaceae (p<0.01). Our observations suggest that the local breast microbiota differ in patients with and without breast cancer. Cancer patient urinary microbiomes were characterized by increased levels of gram-positive organisms in this study, but need to be further studied in larger cohorts. Impact Journals LLC 2017-08-14 /pmc/articles/PMC5675698/ /pubmed/29152146 http://dx.doi.org/10.18632/oncotarget.21490 Text en Copyright: © 2017 Wang et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Paper
Wang, Hannah
Altemus, Jessica
Niazi, Farshad
Green, Holly
Calhoun, Benjamin C.
Sturgis, Charles
Grobmyer, Stephen R.
Eng, Charis
Breast tissue, oral and urinary microbiomes in breast cancer
title Breast tissue, oral and urinary microbiomes in breast cancer
title_full Breast tissue, oral and urinary microbiomes in breast cancer
title_fullStr Breast tissue, oral and urinary microbiomes in breast cancer
title_full_unstemmed Breast tissue, oral and urinary microbiomes in breast cancer
title_short Breast tissue, oral and urinary microbiomes in breast cancer
title_sort breast tissue, oral and urinary microbiomes in breast cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675698/
https://www.ncbi.nlm.nih.gov/pubmed/29152146
http://dx.doi.org/10.18632/oncotarget.21490
work_keys_str_mv AT wanghannah breasttissueoralandurinarymicrobiomesinbreastcancer
AT altemusjessica breasttissueoralandurinarymicrobiomesinbreastcancer
AT niazifarshad breasttissueoralandurinarymicrobiomesinbreastcancer
AT greenholly breasttissueoralandurinarymicrobiomesinbreastcancer
AT calhounbenjaminc breasttissueoralandurinarymicrobiomesinbreastcancer
AT sturgischarles breasttissueoralandurinarymicrobiomesinbreastcancer
AT grobmyerstephenr breasttissueoralandurinarymicrobiomesinbreastcancer
AT engcharis breasttissueoralandurinarymicrobiomesinbreastcancer